Uxin shares drop 45% as predicted by InvestingPro’s Fair Value model
LONDON - Cellbxhealth plc (LSE:CLBX) announced today the launch of a retail offer of new ordinary shares at an issue price of 1.0 pence per share, representing a 38 percent discount to the closing share price of 1.6 pence on November 24.
The retail offer, which opened today, will run until December 1, 2025, and is being conducted via the BookBuild platform. The company stated that the offer is conditional upon shareholder approval at a general meeting scheduled for December 15, with admission of the retail offer shares expected on December 18.
According to the company’s announcement, the retail offer complements a separate conditional placing and subscription of new shares at the same issue price. The combined fundraising aims to generate capital that the company plans to allocate across several areas, including £1.9 million for research and development, £1.0 million for sales and marketing, and £1.1 million for restructuring and cost optimization.
Cellbxhealth indicated that the retail offer is specifically designed to allow its UK retail shareholder base to participate in the fundraising alongside institutional investors. Existing retail shareholders can participate through their brokers or wealth managers, provided these intermediaries are onboarded to the BookBuild platform.
Cavendish Capital Markets Limited is acting as the retail offer coordinator for the transaction.
The company noted that the retail offer may close early if oversubscribed, and investors should be aware that financial intermediaries may set earlier closing times than the official deadline.
This information is based on a press release statement issued by Cellbxhealth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.